Pursuing Health & Wellness Beyond Traditional Medicine

As the body ages, bones weaken and become brittle, increasing the risk of falling and fractures. Each year, about one-third of elderly individuals 65 years and older will fall, many of whom will suffer broken bones. Conditions such as osteoporosis also increase the risk of fracture and often go unnoticed until more serious problems occur.

Calcium is not only great for bone health; it is also the most common bone-health supplement used to prevent osteoporosis. However, it’s difficult for the body to absorb. Vitamins D3 and K2 help improve calcium absorption, but the improvement is limited. An imperative exists to find a supplement that not only provides nutrients to support bone health but also a formulation that increases calcium absorption directly.

EuBone^TM for Increased Bone Mineral Density (BMD) and More

EuBone^TM from Chenland Nutritionals is formulated with three traditional Chinese herbs known for bone health: Eucommia (E. ulmoides)¹, Drynaria (D. fortunei), and Chinese Dodder (C. chinensis Lam). In two separate preclinical trials, EuBone^TM boosted bone health through bone formation and resorption.

In the first study, 0.5 g and 1 g of EuBone^TM was administered in OVX rats for eight weeks. Compared to the placebo, treated rats saw an increase in bone strength, bone density, bone volume/tissue volume, and trabecular number by 36%, 32%, 29%, and 26%, respectively, and a decrease in trabecular separation by 31%.

In the second study, glucocorticoid-induced osteoporosis (GIO) female rats received 1 g, 1.5 g, and 2 g of EuBone^TM for eight weeks. All markers studied indicated EuBone^TM boosted BMD consistently. Calcium and phosphorus concentrations increased in blood serum by 20% and 19%, respectively, and decreased in urine by 19% and 23%, respectively, compared to the placebo group.

Chenland Validates the Health Benefits of Natural Botanical Herbs

Chenland’s process starts with traditional medicine and well-authenticated herbs. In vitro studies, preclinical animal trials, mechanism-of-action studies via proteomic biotechnology, and toxicity studies are then carried out to validate efficacy and safety. Once formulas are deemed satisfactory, human clinical trials are conducted.

With this fully implemented platform, Chenland developed JointAlive^® for joint health², EuBone^TM for bone health, JadeImmune^TM for immune health, MoodElite^® or mood enhancement, and CuminUP60^® for high-load, high-bioavailability curcumin.

We strive to revitalize the multitude of benefits traditional medicine can provide by combining innovative scientific advancement with clinically backed and branded ingredients to ensure the health and well-being of customers for years to come.

For more information, visit chenland.com.

References

Li Yang et al. “Effect of total glycosides from Eucommia ulmoidesseed on bone microarchitecture in rats.” Phytotherapy Research, 2011;25(12):1895-1897

Safety and Efficacy of JointAlive^TM on the Knee-joint Function in Adults with Knee Arthritis, ClinicalTrials.gov Identifier: NCT0439554